Stoke Therapeutics, Inc.

STOK

$29.37

Name : Stoke Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $1,829,212,288.00

EPSttm : -2.86

Stoke Therapeutics, Inc.

$29.37

1.28%

$0.37

STOK — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

26.25

Margin Of Safety %

Put/Call OI Ratio

0.51

EPS Next Q Diff

-0.02

EPS Last/This Y

-3.13

EPS This/Next Y

0.14

Price

29.38

Target Price

45.1

Analyst Recom

Performance Q

-23.42

Upside

-225.7%

Beta

1.2

Ticker: STOK

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	STOK	32.67	2.12	1.83	4150
2026-05-12	STOK	32.53	2.11	13.67	4156
2026-05-13	STOK	31.7	2.11	16.50	4156
2026-05-14	STOK	31.38	2.11	0.43	4157
2026-05-15	STOK	30.15	2.03	0.34	4031
2026-05-18	STOK	29.04	0.67	0.01	637
2026-05-19	STOK	29.98	0.46	5.00	825
2026-05-20	STOK	30.29	0.50	0.43	861
2026-05-21	STOK	29.65	0.49	0.64	880
2026-05-22	STOK	29.34	0.50	0.02	899
2026-05-26	STOK	31.05	0.46	10.40	944
2026-05-27	STOK	31.43	0.54	0.00	1000
2026-05-28	STOK	31.59	0.53	0.09	1011
2026-05-29	STOK	30.91	0.53	6.67	1017
2026-06-02	STOK	28.65	0.51	0.00	1004
2026-06-03	STOK	29.42	0.50	0.00	1008
2026-06-04	STOK	30.16	0.50	0.00	1008
2026-06-05	STOK	30.06	0.51	0.00	1009
2026-06-08	STOK	29.01	0.51	0.00	1005
2026-06-09	STOK	29.33	0.51	999.99	1011
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	STOK	32.64	-98.5	-	-3.32
2026-05-12	STOK	32.46	-98.5	-	-3.32
2026-05-13	STOK	31.71	-90.0	-	-3.32
2026-05-14	STOK	31.36	-90.0	-	-3.32
2026-05-15	STOK	30.09	-90.0	-	-3.25
2026-05-18	STOK	29.03	-90.0	-	-3.25
2026-05-19	STOK	29.97	-90.0	-	-3.25
2026-05-20	STOK	30.30	-90.0	-	-3.25
2026-05-21	STOK	29.67	-90.0	-	-3.25
2026-05-22	STOK	29.33	-90.0	-	-3.25
2026-05-26	STOK	31.02	-90.0	-	-3.25
2026-05-27	STOK	31.43	-90.0	-	-3.25
2026-05-28	STOK	31.58	-90.0	-	-3.25
2026-05-29	STOK	30.91	-90.0	-	-3.25
2026-06-01	STOK	30.54	-90.0	-	-3.25
2026-06-02	STOK	28.62	-90.0	-	-3.25
2026-06-03	STOK	29.43	-90.0	-	-3.25
2026-06-04	STOK	30.15	-90.0	-	-3.25
2026-06-05	STOK	30.02	-90.0	-	-3.25
2026-06-08	STOK	29.01	-90.0	-	-3.25
2026-06-09	STOK	29.38	-90.0	-	-3.25
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	STOK	-1.69	7.05	25.61
2026-05-12	STOK	-1.69	7.05	26.62
2026-05-13	STOK	-1.69	7.05	26.62
2026-05-14	STOK	-1.69	7.05	26.62
2026-05-15	STOK	-1.69	7.05	26.62
2026-05-18	STOK	-1.69	1.45	26.47
2026-05-19	STOK	-1.43	1.45	26.47
2026-05-20	STOK	-1.43	1.45	26.47
2026-05-21	STOK	-1.43	1.45	26.47
2026-05-22	STOK	-1.43	1.45	26.47
2026-05-26	STOK	-1.43	6.99	26.47
2026-05-27	STOK	-1.12	6.99	26.47
2026-05-28	STOK	-1.12	6.99	26.25
2026-05-29	STOK	-1.12	6.99	26.25
2026-06-02	STOK	-1.12	6.21	26.25
2026-06-03	STOK	-1.12	6.21	26.25
2026-06-04	STOK	-1.06	6.21	26.25
2026-06-05	STOK	-1.06	6.21	26.25
2026-06-08	STOK	-0.83	6.23	26.25
2026-06-09	STOK	-0.83	6.23	26.25
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.79

Avg. EPS Est. Current Quarter

-0.76

Avg. EPS Est. Next Quarter

-0.81

Insider Transactions

-0.83

Institutional Transactions

6.23

Beta

1.2

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

29.4

Max Drawdown 5-Year %

-91.8

Target Price

45.1

P/E

Forward P/E

PEG

P/S

57.02

P/B

4.63

P/Free Cash Flow

EPS

-2.84

Average EPS Est. Cur. Y

-3.25

EPS Next Y. (Est.)

-3.1

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-529.2

Relative Volume

0.63

Return on Equity vs Sector %

-70.5

Return on Equity vs Industry %

-54.3

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.12

EBIT Estimation

◆ STOK Healthcare

$29.37

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

17/25

Volume

9/15

Valuation

12/20

TP/AR

4/10

Options

5/10

RSI

41.2

Range 1M

30.5%

Sup Dist

3.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

7/30

Estimates

2/20

Inst/Vol

6/15

Options

6/10

EPS Yr

-2584.7%

EPS NY

3.2%

52W%

64.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +53.6% upside

Quality

6/30

Valuation

11/30

Growth

4/25

Stability

9/10

LT Trend

3/5

Upside

+53.6%

Quality

Stoke Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 170

Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in Phase 1 clinical trials for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase 3 clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.

STOK

Latest News

—

Caricamento notizie per STOK…

stock quote shares STOK – Stoke Therapeutics, Inc. Stock Price stock today

news today STOK – Stoke Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch STOK – Stoke Therapeutics, Inc. yahoo finance google finance

stock history STOK – Stoke Therapeutics, Inc. invest stock market

stock prices STOK premarket after hours

ticker STOK fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: STOK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y